Strides Arcolab’s subsidiary - Onco Therapies has got a tentative approval of US Food and Drug Administration (USFDA) for generic Oxaliplatin injection. The tentative approval is for 50 mg and 100 mg strengths of the injection.
Oxaliplatin is a platinum-based complex that is prescribed in chemotherapy treatment of colorectal cancer and marketed by French pharmaceutical company Sanofi-Aventis under the brand name Eloxatin.
Recently, Onco Therapies had received USFDA approval for Carboplatin Injection 10 mg/mL packaged in 50mg/mL, 150mg/mL, 450 mg/45 mL and 600 mg/60 mL Multi-dose vials.
Strides Arcolab is a global pharmaceuticals headquartered in Bangalore, India that develops and manufactures a wide range of IP-led niche pharmaceuticals products with an emphasis on sterlite injectables.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: